Get all your news in one place.
100's of premium titles.
One app.
Start reading
Medical Daily
Medical Daily
Dorothy Brooks

Moderna Added 45 Billion Dollars in a Day on a Melanoma Vaccine Result with No Effect Size Disclosed

A Landmark Result Announced Without Numbers

Moderna and Merck reported that their personalized mRNA cancer vaccine succeeded in a Phase 3 melanoma trial. Moderna's market value rose by nearly $45 billion in a single session, with the two companies and rival BioNTech gaining around $92 billion collectively. Neither partner released an efficacy figure.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.